Clinical review: status epilepticus
- PMID: 11983039
- PMCID: PMC137295
- DOI: 10.1186/cc1472
Clinical review: status epilepticus
Abstract
Status epilepticus (SE) has an annual incidence exceeding 100,000 cases in the United States alone, of which more than 20% result in death. Thus, increased awareness of presentation, etiologies, and treatment of SE is essential in the practice of critical care medicine. This review discusses current definitions of SE, as well as its clinical presentation and classification. The recent literature on epidemiology is reviewed, including morbidity and mortality data. An overview of the systemic pathophysiologic effects of SE is presented. Finally, significant studies on the treatment of acute SE and refractory SE are reviewed, including the use of anticonvulsants, such as benzodiazepines, and other drugs.
Figures
References
-
- Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and elec-trographic classification of epileptic seizures. Epilepsia. 1981;22:489–501. - PubMed
-
- Nevander G, Ingvar M, Auer R, Siesjo BK. Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol. 1985;18:281–290. - PubMed
-
- Meldrum BS, Horton RW. Physiology of status epilepticus in primates. Arch Neurol. 1973;28:1–9. - PubMed
-
- Lothman EW. The biochemical basis and pathophysiology of status epilepticus. Neurology. 1990;40(suppl):13–23. - PubMed
-
- DeLorenzo RJ, Garnett LK, Towne AR, Waterhouse EJ, Boggs JG, Morton L, Choudhry MA, Barnes T, Ko D. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999;40:164–169. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
